Trial NCT02875067

View at ClinicalTrials.gov 
Org. Study IDs: 15-00285

Last trial update was posted on 2020-08-14

MeSH Interventions

Lenalidomide Pembrolizumab

MeSH Conditions

Hodgkin Disease Lymphoma

Other Conditions

Relapsed Hodgkin Lymphoma Relapsed Non-Hodgkin Lymphoma

Stopping Reasons

Merck's decision for early termination of the data

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID